GlassScriptPhysician profile
Renee Hammoud
NPI 1790264711
$828.34
in general payments reported to CMS, 2019-2025
15 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $55.67 · 2024: $614 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $164.35 | 2024 | Arcalyst |
| Amgen INC. | $118.78 | 2023-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $107.08 | 2024 | Xarelto |
| Pfizer INC. | $102.81 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $79.45 | 2024-2025 | Wainua, Farxiga |
| Sanofi-Aventis U.S. LLC | $40.36 | 2024 | |
| Scpharmaceuticals INC. | $39.49 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $28.20 | 2024 | Verquvo |
| Abbott Laboratories | $25.13 | 2025 | Cardiomems |
| Boston Scientific Corporation | $24.46 | 2025 | Watchman Access System |
| Novartis Pharmaceuticals Corporation | $24.22 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $20.65 | 2023 | Arcalyst |
| Inspire Medical Systems, INC. | $19.14 | 2024 | Inspire |
| Bridgebio Pharma, INC. | $17.29 | 2025 | Attruby |
| Abiomed | $16.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Hammoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.